RHYTHM PHARMACEUTICALS, INC. (RYTM)
Clinical trial NCT05818098 updates: 1. status: UNKNOWN → COMPLETED 2. completion date: 2024-03-01 → 2023-09-15 3. primary completion date: 2023-09-01 → 2023-09-15 4. enrollment type: ESTIMATED → ACTUAL 5. collaborators added: Shengjing Hospital, The People's Hospital of Liaoning Province, Wuhan Central Hospital, Xiamen Cardiovascular Hospital, Xiamen University, Shanxi Bethune Hospital, Huai'an First People's Hospital, The Second Hospital of Hebei Medical University, Shanxi Cardiovascular Hospital, Shanghai East Hospital, Linfen No.4 People's Hospital, Three Gorges Hospital of Chongqing University, The First Hospital of Jilin University, The Second Affiliated Hospital of Harbin Medical University, People's Hospital of Xinjiang Uygur Autonomous Region, First Affiliated Hospital Xi'an Jiaotong University, West China Hospital, First Hospital of China Medical University, Hebei Provincial People's Hospital
📊 **NEUTRAL** • Medium confidence analysis (70%) • Weak clinical signals • Minimal impact anticipated **Sentiment:** Neutral (50%) **Content type:** Clinical